MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis

BACKGROUND: Triple-negative breast cancer (TNBC) is the most aggressive type of breast cancer that lacks ER/PR and HER2 receptors. Hence, there is urgency in developing new or novel therapeutic strategies for treatment of TNBC. Our study shows that the Monocyte Chemoattractant Protein-1 (MCP-1) is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutta, Pranabananda, Sarkissyan, Marianna, Paico, Kimberly, Wu, Yanyuan, Vadgama, Jaydutt V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022526/
https://www.ncbi.nlm.nih.gov/pubmed/29594759
http://dx.doi.org/10.1007/s10549-018-4760-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022526/
https://www.ncbi.nlm.nih.gov/pubmed/29594759
http://dx.doi.org/10.1007/s10549-018-4760-8

Ejemplares similares